Digoxin therapy may reduce the risk for new-onset or worsening heart failure in patients with symptomatic rheumatic heart disease.

NEW ORLEANS, LA—Treating patients with symptomatic rheumatic heart disease (RHD) with digoxin appears to modestly reduce the risk of all-cause mortality or new-onset or worsening heart failure (HF), ...

In patients with heart failure with reduced ejection fraction (HFrEF) who have an implantable cardioverter-defibrillator (ICD), the use of digoxin may increase the risk of ventricular tachyarrhythmia ...

A randomized trial shows no significant difference in the primary endpoint of quality of life at 6 months between treatment with digoxin vs the beta-blocker bisoprolol (Zebeta) in patients with atrial ...

Patients with rheumatic heart disease who took the heart failure drug digoxin were 18% less likely to die or experience new-onset or worsening heart failure during a two-year follow-up compared with ...

Digoxin, a cardiac glycoside derived from the foxglove plant, has been a mainstay of treatment in systolic heart failure and in rate control for atrial fibrillation. By inhibiting the cardiac ...

We wish to report our experience with 72 patients who were treated with acetyldigitoxin. § Forty-nine were given a full digitalizing dose and maintained thereafter on acetyldigitoxin, whereas 23 ...

A major clinical trial, led by researchers from All India Institute of Medical Sciences (AIIMS), has found that the low-cost heart drug digoxin may help reduce worsening heart failure in patients ...

Millions of Americans take a daily handful of supplements alongside prescription heart or thyroid drugs, often without telling their doctors. Federal research and clinical pharmacology studies show ...